Lars Wortmann
Impact in
- Cell Biology top 10%
- Microtubule and mitosis dynamics
- Molecular Biology top 10%
- Protein Kinase Regulation and GTPase Signaling
- Protein Degradation and Inhibitors
- DNA Repair Mechanisms
Papers in
-
- Asymmetric Synthesis and Catalysis 5
- Advanced Synthetic Organic Chemistry 3
- Organic Chemistry Synthesis Methods 2
-
- Computational Drug Discovery Methods 6
- Co-authors
- Dieter Enders (4 shared papers)René Peters (1 shared paper)Michael Brands (2 shared papers)Katrin Juenemann (1 shared paper)Laura Martina Luh (1 shared paper)Philipp M. Cromm (1 shared paper)Dominik Mumberg (4 shared papers)Gerhard Siemeister (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (6 papers)Journal of Chemical Information and Modeling (3 papers)Molecular Cell (2 papers)Angewandte Chemie International Edition (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- GermanyCanadaUnited States
In The Last Decade
Lars Wortmann
24 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 62
- Cell Biology 146
- Molecular Biology 596
- Oncology 201
- Organic Chemistry 255
- Computational Theory and Mathematics 104
Countries citing papers authored by Lars Wortmann
This map shows the geographic impact of Lars Wortmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Wortmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Wortmann more than expected).
Fields of papers citing papers by Lars Wortmann
This network shows the impact of papers produced by Lars Wortmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Wortmann. The network helps show where Lars Wortmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Wortmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 320 | |
| 2 | 2019 | 176 | |
| 3 | 2007 | 165 | |
| 4 | 2020 | 162 | |
| 5 | 2000 | 111 | |
| 6 | 2020 | 63 | |
| 7 | 2020 | 41 | |
| 8 | 2018 | 38 | |
| 9 | 2024 | 23 | |
| 10 | 2018 | 20 | |
| 11 | 2021 | 19 | |
| 12 | 2011 | 17 | |
| 13 | 2023 | 17 | |
| 14 | 2019 | 16 | |
| 15 | 2016 | 14 | |
| 16 | 2021 | 14 | |
| 17 | 2013 | 12 | |
| 18 | 2025 | 9 | |
| 19 | 1999 | 8 | |
| 20 | 2002 | 4 |
About Lars Wortmann
Lars Wortmann is a scholar working on Organic Chemistry, Computational Theory and Mathematics, Molecular Biology, Oncology and Infectious Diseases, having authored 25 papers that have together received 1.3k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (6 papers), Asymmetric Synthesis and Catalysis (5 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), DNA Repair Mechanisms (3 papers), Advanced Synthetic Organic Chemistry (3 papers), PARP inhibition in cancer therapy (3 papers), RNA Research and Splicing (2 papers) and Organic Chemistry Synthesis Methods (2 papers). The work is most often cited by research in Cell Biology (146 citations), Molecular Biology (596 citations), Oncology (201 citations), Organic Chemistry (255 citations) and Computational Theory and Mathematics (104 citations). Lars Wortmann has collaborated with scholars based in Germany, Canada and United States. Frequent co-authors include Dieter Enders, René Peters, Michael Brands, Katrin Juenemann, Laura Martina Luh, Philipp M. Cromm, Dominik Mumberg, Gerhard Siemeister, Uwe Eberspächer and Volker Schulze. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Chemical Information and Modeling, Molecular Cell, Angewandte Chemie International Edition and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.